Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Jan 28;4(3):463–470. doi: 10.1158/1940-6207.CAPR-10-0266

Table 3.

Early stage ovarian or fallopian tube cancers identified in BRCA mutation carriers

Case # Age at dx BRCA1/2 Mutation Grade Dominant Mass Histology Bilateral or Unilateral? Primary size Stage
7 32 BRCA1 high ovary serous carcinoma bilateral 12 × 6 × 6 cm IB
8 43 BRCA1 high ovary serous carcinoma unknown unknown IIA
9 56 BRCA1 high ovary serous carcinoma bilateral 11 cm IC
10 55 BRCA1 high ovary serous carcinoma unilateral 8 cm IIC
11 54 BRCA1 high ovary undifferentiated carcinoma unilateral unknown IA
12 50 BRCA1 high fallopian tube poorly differentiated carcinoma unilateral 2 cm IA
13 40 BRCA1 high fallopian tube serous carcinoma unilateral 8 × 5 × 3 cm II
14 50 BRCA1 high fallopian tube serous carcinoma unilateral 2 × 1 × 1 cm IA

15 54 BRCA2 high ovary poorly differentiated carcinoma unilateral 7 × 7 × 5 cm IIB
16 59 BRCA2 high ovary serous carcinoma bilateral 7 cm IIC
17 55 BRCA2 high ovary serous carcinoma bilateral 14 × 7 × 6 cm IB
18 50 BRCA2 high ovary serous carcinoma bilateral 7 × 5 × 3 cm IIA
19 61 BRCA2 high ovary serous carcinoma unilateral 15 cm IIA

20 41 BRCA1 and BRCA2 high ovary serous carcinoma involving left ovary and detached fragments in RFT lumen unilateral 6 cm IIB

RFT, right fallopian tube.